New eye drops tested for safety in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage trial is testing whether IVMED-85 eye drops are safe for healthy adults aged 18 to 49. About 36 participants will use the eye drops or a placebo twice daily for 6 weeks. The study focuses on vision changes and eye discomfort, not on treating any disease.
Phase: PHASE1 • Sponsor: iVeena Delivery Systems, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC